sirolimus and Fetal-Macrosomia

sirolimus has been researched along with Fetal-Macrosomia* in 1 studies

Other Studies

1 other study(ies) available for sirolimus and Fetal-Macrosomia

Article	Year
Old treatments for new genetic conditions: Sirolimus therapy in a child affected by mosaic overgrowth with fibroadipose hyperplasia. Clinical genetics, 2019, Volume: 96, Issue:1 PIK3CA-related overgrowth spectrum (PROS) are overgrowth diseases involving mesenchymal tissues caused by postzygotic variants in the PIK3CA gene. Fibro-Adipose hyperplasia or Overgrowth (FAO) belongs to PROS. We reported the beneficial effect of oral low-dose sirolimus therapy in a child affected by progressive FAO in term of stabilization of the disease, good tolerability, and easy management. Topics: Absorptiometry, Photon; Adipose Tissue; Child, Preschool; Fetal Macrosomia; Genetic Predisposition to Disease; Humans; Hyperplasia; Magnetic Resonance Imaging; Mosaicism; Sirolimus; Treatment Outcome	2019

Article

Year

Old treatments for new genetic conditions: Sirolimus therapy in a child affected by mosaic overgrowth with fibroadipose hyperplasia.

Clinical genetics, 2019, Volume: 96, Issue:1

PIK3CA-related overgrowth spectrum (PROS) are overgrowth diseases involving mesenchymal tissues caused by postzygotic variants in the PIK3CA gene. Fibro-Adipose hyperplasia or Overgrowth (FAO) belongs to PROS. We reported the beneficial effect of oral low-dose sirolimus therapy in a child affected by progressive FAO in term of stabilization of the disease, good tolerability, and easy management.

Topics: Absorptiometry, Photon; Adipose Tissue; Child, Preschool; Fetal Macrosomia; Genetic Predisposition to Disease; Humans; Hyperplasia; Magnetic Resonance Imaging; Mosaicism; Sirolimus; Treatment Outcome

2019